Management of Primary Central Nervous System Lymphoma Using Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption: Retrospective Analysis of the Sherbrooke Cohort.

Front Oncol · 2020 · PMC7855856 · PMID 33552946

Europe PMC DOI

hedged sentence

0.2390

closest p · 4.8× alpha

0.2390

boldest claim

The sentences

did not reach statistical significancep = .239not close (p > 0.1)

There was a trend towards better survival and PFS when carboplatin was added to the regimen ( Figure 4A ), although this did not reach statistical significance (p = .239) either in the univariate or multivariate analysis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.